Efficacy and tolerability of sofosbuvir and daclatasvir for treatment of hepatitis C genotype 1 & 3 in patients undergoing hemodialysis- a prospective interventional clinical trial
出版年份 2019 全文链接
标题
Efficacy and tolerability of sofosbuvir and daclatasvir for treatment of hepatitis C genotype 1 & 3 in patients undergoing hemodialysis- a prospective interventional clinical trial
作者
关键词
-
出版物
BMC Nephrology
Volume 20, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-11-29
DOI
10.1186/s12882-019-1631-4
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- The efficacy and safety of glecaprevir plus pibrentasvir in 141 patients with severe renal impairment: a prospective, multicenter study
- (2019) Masanori Atsukawa et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- HCV treatment initiation in persons with chronic kidney disease in the directly acting antiviral agents era: Results from ERCHIVES
- (2018) Adeel A. Butt et al. LIVER INTERNATIONAL
- Efficacy and safety of ombitasvir/paritaprevir/ritonavir in dialysis patients with genotype 1b chronic hepatitis C
- (2017) Masanori Atsukawa et al. HEPATOLOGY RESEARCH
- Daclatasvir and asunaprevir in hemodialysis patients with hepatitis C virus infection: a nationwide retrospective study in Japan
- (2017) Goki Suda et al. JOURNAL OF GASTROENTEROLOGY
- Safety and efficacy of daclatasvir-sofosbuvir in HCV genotype 1-mono-infected patients
- (2017) Stanislas Pol et al. JOURNAL OF HEPATOLOGY
- Efficacy and safety of direct-acting antivirals-based antiviral therapies for hepatitis C virus patients with stage 4-5 chronic kidney disease: a meta-analysis
- (2017) Tao Li et al. LIVER INTERNATIONAL
- Successful Treatment of Hepatitis C in Renal Transplant Recipients With Direct-Acting Antiviral Agents
- (2016) D. Sawinski et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Pharmacokinetics, safety and efficacy of a full dose sofosbuvir-based regimen given daily in hemodialysis patients with chronic hepatitis C
- (2016) Aude Desnoyer et al. JOURNAL OF HEPATOLOGY
- Hepatitis C virus prevalence and genotype distribution in Pakistan: Comprehensive review of recent data
- (2016) Muhammad Umer WORLD JOURNAL OF GASTROENTEROLOGY
- Single-dose pharmacokinetics and safety of daclatasvir in subjects with renal function impairment
- (2015) Tushar Garimella et al. ANTIVIRAL THERAPY
- Safety, efficacy and tolerability of half-dose sofosbuvir plus simeprevir in treatment of Hepatitis C in patients with end stage renal disease
- (2015) Bhamidimarri Kalyan Ram et al. JOURNAL OF HEPATOLOGY
- Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection
- (2015) Jordan J. Feld et al. NEW ENGLAND JOURNAL OF MEDICINE
- Daclatasvir plus Sofosbuvir for HCV Infection
- (2014) NEW ENGLAND JOURNAL OF MEDICINE
- Pegylated Interferon-α2a With or Without Low-Dose Ribavirin for Treatment-Naive Patients With Hepatitis C Virus Genotype 1 Receiving Hemodialysis
- (2013) Chen-Hua Liu et al. ANNALS OF INTERNAL MEDICINE
- Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options
- (2013) Ira M. Jacobson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nucleotide Polymerase Inhibitor Sofosbuvir plus Ribavirin for Hepatitis C
- (2013) Edward J. Gane et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection
- (2013) Eric Lawitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interferon Treatment in Hemodialysis Patients With Chronic Hepatitis C Virus Infection: A Systematic Review of the Literature and Meta-analysis of Treatment Efficacy and Harms
- (2008) Craig E. Gordon et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Guideline 4: Management of HCV-infected patients before and after kidney transplantation
- (2008) KIDNEY INTERNATIONAL
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now